A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

The Nobel Prize in Medicine was awarded on Monday to three scientists for discovering how a particular kind of cell can stop ...

Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...

The drugmaker has launched an international Phase I trial, dubbed Breakfree-2, in seven countries to test the autologous therapy.

Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...

However, details of the intervening steps, as researchers have learned in the past 65 years, are quite complex — certain cells carry the flu antigen to the immune system, specific immune cells respond ...

Two recent studies identified gene knockouts that may make CAR T-cell therapy more effective, but the next step is applying the hypotheses in humans.